Nifedipine suppresses Th1/Th2 cytokine production and increased apoptosis of anti-CD3 + anti-CD28-activated mononuclear cells from patients with systemic lupus erythematosus via calcineurin pathway

Wang, 1976, A brain protein and its effect on the Ca2+- and protein modulator-activated cyclic nucleotide phosphodiesterase, Biochem. Biophys. Res. Commun., 72, 926, 10.1016/S0006-291X(76)80220-3 Klee, 1979, Calcineurin: a calcium- and calmodulin-binding protein of the nervous system, Proc. Natl. Acad. Sci. U. S. A., 76, 6270, 10.1073/pnas.76.12.6270 Feske, 2003, Ca2+/calcineurin signalling in cells of the immune system, Biochem. Biophys. Res. Commun., 311, 1117, 10.1016/j.bbrc.2003.09.174 Baksh, 2000, The role of calcineurin in lymphocyte activation, Semin. Immunol., 12, 405, 10.1006/smim.2000.0221 Macian, 2005, NFAT proteins: key regulators of T-cell development and function, Nat. Rev. Immunol., 5, 472, 10.1038/nri1632 Shibasaki, 2002, Calcineurin as a multifunctional regulator, J. Biochem. (Tokyo), 131, 1, 10.1093/oxfordjournals.jbchem.a003063 Sussman, 1998, Prevention of cardiac hypertrophy in mice by calcineurin inhibition, Science, 281, 1690, 10.1126/science.281.5383.1690 Asai, 1999, High level calcineurin activity predisposes neuronal cells to apoptosis, J. Biol. Chem., 274, 34450, 10.1074/jbc.274.48.34450 Yoo, 2006, Calcineurin is expressed and plays a critical role in inflammatory arthritis, J. Immunol., 177, 2681, 10.4049/jimmunol.177.4.2681 Gallo, 2006, Lymphocyte calcium signaling from membrane to nucleus, Nat. Immunol., 7, 25, 10.1038/ni1295 Tsokos, 1999, Immune cell signaling defects in lupus: activation, anergy and death, Immunol. Today, 20, 119, 10.1016/S0167-5699(98)01395-4 Liossis, 1998, Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain, J. Clin. Invest., 101, 1448, 10.1172/JCI1457 Vassilopoulos, 1995, TCR/CD3 complex-mediated signal transduction pathway in T cells and T cell lines from patients with systemic lupus erythematosus, J. Immunol., 155, 2269, 10.4049/jimmunol.155.4.2269 Juang, 2005, Systemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV, J. Clin. Invest., 115, 996, 10.1172/JCI22854 Kyttaris, 2007, Increased levels of NF-ATc2 differentially regulate CD154 and IL-2 genes in T cells from patients with systemic lupus erythematosus, J. Immunol., 178, 1960, 10.4049/jimmunol.178.3.1960 Grafton, 2001, Calcium channels in lymphocytes, Immunology, 104, 119, 10.1046/j.0019-2805.2001.01321.x Winslow, 2003, Calcium signalling in lymphocytes, Curr. Opin. Immunol., 15, 299, 10.1016/S0952-7915(03)00050-5 Kotturi, 2003, Identification and functional characterization of voltage-dependent calcium channels in T lymphocytes, J. Biol. Chem., 278, 46949, 10.1074/jbc.M309268200 Ogino, 2007, Amlodipine inhibits granulation tissue cell apoptosis through reducing calcineurin activity to attenuate postinfarction cardiac remodeling, Am. J. Physiol. Heart Circ. Physiol., 293, H2271, 10.1152/ajpheart.00303.2007 Tan, 1982, The 1982 revised criteria for the classification of systemic lupus erythematosus, Arthritis Rheum., 25, 1271, 10.1002/art.1780251101 Dhein, 1995, Autocrine T-cell suicide mediated by APO-1/(Fas/CD95), Nature, 373, 438, 10.1038/373438a0 Ju, 1995, Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation, Nature, 373, 444, 10.1038/373444a0 Alderson, 1995, Fas ligand mediates activation-induced cell death in human T lymphocytes, J. Exp. Med., 181, 71, 10.1084/jem.181.1.71 Brunner, 1995, Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas, Nature, 373, 441, 10.1038/373441a0 Kammer, 2002, Abnormal T cell signal transduction in systemic lupus erythematosus, Arthritis Rheum., 46, 1139, 10.1002/art.10192 Sipka, 2001, Glucocorticosteroid dependent decrease in the activity of calcineurin in the peripheral blood mononuclear cells of patients with systemic lupus erythematosus, Ann. Rheum. Dis., 60, 380, 10.1136/ard.60.4.380 Rider, 1998, Gender differences in autoimmune diseases: estrogen increases calcineurin expression in systemic lupus erythematosus, Clin. Immunol. Immunopathol., 89, 171, 10.1006/clin.1998.4604 Platzer, 1999, Cyclic adenosine monophosphate-responsive elements are involved in the transcriptional activation of the human IL-10 gene in monocytic cells, Eur. J. Immunol., 29, 3098, 10.1002/(SICI)1521-4141(199910)29:10<3098::AID-IMMU3098>3.0.CO;2-H Samten, 2005, Cyclic AMP response element-binding protein positively regulates production of IFN-gamma by T cells in response to a microbial pathogen, J. Immunol., 174, 6357, 10.4049/jimmunol.174.10.6357 Griffiths, 2001, The treatment of lupus with cyclosporin A, Lupus, 10, 165, 10.1191/096120301672970034 Feske, 2001, Gene regulation mediated by calcium signals in T lymphocytes, Nat. Immunol., 2, 316, 10.1038/86318 Cominacini, 1997, Lacidipine inhibits the activation of the transcription factor NF-kappaB and the expression of adhesion molecules induced by pro-oxidant signals on endothelial cells, J. Hypertens., 15, 1633, 10.1097/00004872-199715120-00065 Badou, 1997, HgCl2-induced interleukin-4 gene expression in T cells involves a protein kinase C-dependent calcium influx through L-type calcium channels, J. Biol. Chem., 272, 32411, 10.1074/jbc.272.51.32411 Savignac, 2004, Dihydropyridine receptors are selective markers of Th2 cells and can be targeted to prevent Th2-dependent immunopathological disorders, J. Immunol., 172, 5206, 10.4049/jimmunol.172.9.5206 Gomes, 2007, Calcium channel blocker prevents Th2-cell mediated airway inflammation, Am. J. Respir. Crit. Care Med., 175, 1117, 10.1164/rccm.200607-1026OC Yoshii, 2006, Regression of atherosclerosis by amlodipine via anti-inflammatory and anti-oxidative stress actions, Hypertens. Res., 29, 457, 10.1291/hypres.29.457 Morgano, 1990, Decreased lymphocyte blastogenesis, IL2 production and NK activity following nifedipine administration to healthy humans, Eur. J. Clin. Pharmacol., 39, 545, 10.1007/BF00316092 Kahan, 1982, Controlled study of nifedipine in the treatment of Raynaud's phenomenon, Rev. Rhum. Mal. Osteoartic., 49, 337 Kahan, 1983, Calcium entry blocking agents in digital vasospasm (Raynaud's phenomenon), Eur. Heart J., 4, 123, 10.1093/eurheartj/4.suppl_C.123 Kotturi, 2005, Molecular characterization of L-type calcium channel splice variants expressed in human T lymphocytes, Mol. Immunol., 42, 1461, 10.1016/j.molimm.2005.01.014 Savignac, 2001, Protein kinase C-mediated calcium entry dependent upon dihydropyridine sensitive channels: a T cell receptor-coupled signaling pathway involved in IL-4 synthesis, FASEB J., 15, 1577, 10.1096/fj.00-0733fje Suzuki, 1996, Abnormal Fas and Fas ligand expression of lymphocytes in patients with SLE, Nippon Rinsho, 54, 1955 Kovács, 1997, Increased expression of functional Fas-ligand in activated T cells from patients with systemic lupus erythematosus, Autoimmunity, 25, 213, 10.3109/08916939708994730 Georgescu, 1997, Interleukin-10 promotes activation-induced cell death of SLE lymphocytes mediated by Fas ligand, J. Clin. Invest., 100, 2622, 10.1172/JCI119806 Kaplan, 2002, The apoptotic ligands TRAIL, TWEAK, and Fas ligand mediate monocyte death induced by autologous lupus T cells, J. Immunol., 169, 6020, 10.4049/jimmunol.169.10.6020 Aringer, 1994, High levels of bcl-2 protein in circulating T lymphocytes, but not B lymphocytes, of patients with systemic lupus erythematosus, Arthritis Rheum., 37, 1423, 10.1002/art.1780371004 Fruman, 1992, Correlation of calcineurin phosphatase activity and programmed cell death in murine T cell hybridomas, Eur. J. Immunol., 22, 2513, 10.1002/eji.1830221008 Anel, 1994, T cell receptor-induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A, Eur. J. Immunol., 24, 2469, 10.1002/eji.1830241032 Jayaraman, 2000, Calcineurin is downstream of the inositol 1,4,5-trisphosphate receptor in the apoptotic and cell growth pathways, J. Biol. Chem., 275, 6417, 10.1074/jbc.275.9.6417